Kreft B, Bednarczyk M, Emmerling F, Marsch W. Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2011;28(2):134-137.
APA
Kreft, B., Bednarczyk, M., Emmerling, F., & Marsch, W. (2011). Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 28(2), 134-137.
Chicago
Kreft, Burkhard, Magdalena Bednarczyk, Franziska Emmerling, and Wolfgang Christian Marsch. 2011. "Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 28 (2): 134-137.
Harvard
Kreft, B., Bednarczyk, M., Emmerling, F., and Marsch, W. (2011). Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 28(2), pp.134-137.
MLA
Kreft, Burkhard et al. "Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 28, no. 2, 2011, pp. 134-137.
Vancouver
Kreft B, Bednarczyk M, Emmerling F, Marsch W. Case ReportCutaneous-subcutaneous pseudolymphoma after specific immunotherapy with grass-rye pollen-allergen extract containing aluminium hydroxide. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2011;28(2):134-137.
Allergen-specific immunotherapy is an important treatment procedure in IgE-mediated allergic diseases such as allergic rhinitis or insect toxin allergies. A reduction in the clinical reaction to the allergens to which the patient is known to be sensitized is intended by means of antigen-specific influence on the immune system. The allergen-specific immunotherapy can be applied by subcutaneous injections, and for selected allergens by means of sublingual application of the appropriate allergen. Occasionally, the injection of aluminium hydroxide-adsorbed sera induces a usually transient formation of granulomas. We are reporting on a rare case of cutaneous-subcutaneous pseudolymphoma in the injection area of both upper arms, probably induced by subcutaneous allergen-specific immunotherapy.